Clinical Trials in Kintampo, Ghana
4 recruiting
Showing 1–6 of 6 trials
Recruiting
Phase 3
The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease
Sickle Cell Disease
Sanofi192 enrolled54 locationsNCT06975865
Recruiting
Phase 3
A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
Sickle Cell Disease
Novo Nordisk A/S408 enrolled172 locationsNCT06612268
Recruiting
Phase 3
A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia
Sickle Cell DiseaseThalassemia
Novo Nordisk A/S480 enrolled103 locationsNCT06609226
Recruiting
Phase 2
Platform Study to Evaluate the Efficacy and Safety of Anti-malarial Agents in Patients With Uncomplicated Plasmodium Falciparum Malaria
Novartis Pharmaceuticals327 enrolled12 locationsNCT05750628
Recruiting
PRISMA Maternal and Newborn Health Study
Pregnancy, High Risk
George Washington University267,897 enrolled5 locationsNCT05904145
Recruiting
Strengthening the Evidence for Policy on the RTS,S/AS01 Malaria Vaccine
Malaria
Kintampo Health Research Centre, Ghana9,280 enrolled4 locationsNCT05041556